We have developed a new system for measuring photochemical ozone production rates in the atmosphere. Specifically, the system measures the net photochemical oxidant (O: the sum of ozone (O) and nitrogen dioxide (NO)) production rates (P-L(O)). Measuring O avoids issues from perturbations to the photostationary states between nitrogen oxides (NO) and O. This system has "reaction" and "reference" chambers. Ambient air is introduced into both chambers, and O is photochemically produced in the reaction chamber and not generated in the reference chamber. Air from the chambers is alternately introduced into an NO-reaction (NO: nitric oxide) tube to convert O to NO, and then the O concentration is measured as NO using a laser-induced fluorescence technique. P-L(O) was obtained by dividing the difference in O concentrations between air samples from the two chambers by the mean residence time of the air in the reaction chamber. In this study, the P-L(O) measurement system was characterized, and the current detection limit of P-L(O) was determined to be 0.54 ppbv h with an integration time of 60 s (S/N = 2), assuming an ambient O concentration of 100 ppbv. Field measurements of P-L(O) were conducted using the system at a remote forest location.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.6b04639 | DOI Listing |
Elife
January 2025
Eikon Therapeutics Inc, Hayward, United States.
The regulation of cell physiology depends largely upon interactions of functionally distinct proteins and cellular components. These interactions may be transient or long-lived, but often affect protein motion. Measurement of protein dynamics within a cellular environment, particularly while perturbing protein function with small molecules, may enable dissection of key interactions and facilitate drug discovery; however, current approaches are limited by throughput with respect to data acquisition and analysis.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Mental Illness Research, Education and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
Importance: Recently, the US Food and Drug Administration gave premarketing approval to an algorithm based on its purported ability to identify individuals at genetic risk for opioid use disorder (OUD). However, the clinical utility of the candidate genetic variants included in the algorithm has not been independently demonstrated.
Objective: To assess the utility of 15 genetic variants from an algorithm intended to predict OUD risk.
JAMA
January 2025
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Importance: Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of private equity acquisitions of US hospitals on patient care experience.
Objective: To evaluate whether the acquisition of hospitals by private equity firms was associated with changes in measures of patient-reported experience compared with matched control hospitals from 2008 through 2019.
Prehosp Emerg Care
January 2025
Department of Emergency Medicine, College of Medicine, The University of Arizona, Tucson, AZ.
Objectives: Buprenorphine is becoming a key component of prehospital management of opioid use disorder (OUD). It is unclear how many prehospital patients might be eligible for buprenorphine induction, as traditional induction requires that patients first have some degree of opioid withdrawal. The primary aim of this study was to quantify how many patients developed precipitated withdrawal after receiving prehospital naloxone for suspected overdose, as they could be candidates for prehospital buprenorphine.
View Article and Find Full Text PDFDrug Deliv Transl Res
January 2025
School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, UK.
Glaucoma is an optic neuropathy in which progressive degeneration of retinal ganglion cells and the optic nerve leads to irreversible visual loss. Glaucoma is one of the leading causes of blindness. The pathogenesis of glaucoma is determined by different pathogenetic mechanisms, including increased intraocular pressure, mechanical stress, excitotoxicity, resistance to aqueous drainage and oxidative stress.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!